BioAegis Therapeutics Inc.: Clinical Trials

5 trials sponsored by BioAegis Therapeutics Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Recruiting 1
Phase 12Completed 2

Follow BioAegis Therapeutics Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers
Sodium Chloride 0.9% Inj pre-exposure, Sodium Chloride 0.9% Inj post-exposure, Recombinant human plasma gelsolin pre-exposure - Decompression Sickness
Phase 2CompletedBioAegis Therapeutics Inc.362025-08-152026-10-02
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
Rhu-pGSN, normal saline - Acute Respiratory Distress Syndrome, Infections
Phase 2RecruitingBioAegis Therapeutics Inc.6002024-10-032026-10-20
A Study to Evaluate Plasma Gelsolin in Healthy Volunteers
Recombinant human plasma gelsolin, placebo - Volunteers, Healthy
Phase 1CompletedBioAegis Therapeutics Inc.322023-03-142024-09-19
Rhu-pGSN for Severe Covid-19 Pneumonia
Recombinant human plasma gelsolin (Rhu-pGSN), Placebo - Sars-CoV2
Phase 2CompletedBioAegis Therapeutics Inc.642020-07-302023-11-28
A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP
Recombinant Human Plasma Gelsolin, Normal Saline Placebo - Community-acquired Pneumonia
Phase 1 / Phase 2CompletedBioAegis Therapeutics Inc.332018-08-282020-01-27

Conditions studied

COVID-19 (1)  ·  Community-Acquired Pneumonia (1)  ·  Cytokine Release Syndrome (1)  ·  Decompression Sickness (1)  ·  Infections (1)  ·  Lymphoma, Follicular (1)  ·  Pneumonia (1)  ·  Respiratory Distress Syndrome (1)  ·  Respiratory Insufficiency (1)

Interventions

Saline Solution (3)  ·  Gelsolin (1)  ·  Sodium Chloride (1)

Countries

United States (3)  ·  Romania (2)  ·  Spain (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Georgia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Mark J DiNubile, MD (3)

Results publications

PMID 32690640, PMID 42233740